LncRNA BLACATI/miR-5l9d-3p/CREBI Axis Mediates Proliferation, Apoptosis, Migration, Invasion, and Drug-Resistance in Colorectal Cancer Progression

• Published in: Cancer management and research Vol. 12; p. 13137
• Main Authors: Chen, Rui, Zhou, Shenkang, Chen, Jianhui, Lin, Senbin, Ye, Feifei, Jiang, Pinlu
• Format: Journal Article
• Language: English
• Published: Dove Medical Press Limited 31.12.2020
• Subjects: Analysis; Apoptosis; Colorectal cancer; Cyclic adenylic acid; Development and progression; Drug resistance; Drug therapy; Metastasis; Oxalic acid; Protein binding; Proteins; China
• ISSN: 1179-1322; 1179-1322
• DOI: 10.2147/CMAR.S274447

Background: Colorectal cancer (CRC) is a common severe disease around the world. The merging papers reported that long noncoding RNAs (lncRNAs) took part in the diversified pathological processes of CRC. This study aimed to uncover the role and the potential mechanism of lncRNA bladder cancer-associated transcript 1 (BLACAT1) in CRC progression. Methods: LncRNA BLACAT1, micro-519d-3p (miR-519d-3p), and cAMP-responsive element binding protein 1 (CREB1) levels were detected by quantitative real-time polymerase chain reaction (qRT-PCR) in CRC tissues and cells. The bio-functional effects were examined by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT), flow cytometry assay, and transwell assay. The susceptibility testing was determined by oxaliplatin (OXA) administration. The potential binding sites between miR-519d-3p and BLACAT1 or CREB1 were predicted by online software starBase and confirmed by dual-luciferase reporter analysis. The relative proteins expression in CRC cells was determined by Western blot analysis. Xenograft tumor model was used to evaluate biological function of BLACAT1 in vivo. Results: The expression of BLACAT1 was promoted in CRC tissues and cells, and correlated to the TNM (tumor, node, metastasis) stage, distant metastasis, and overall survival rate. Silencing of BLACAT1 limited the proliferation, migration, and invasion, facilitated the apoptosis, and re-sensitized OXA-resistance in CRC cells. MiR-519d-3p was a target of BLACAT1. Furthermore, miR-519d-3p deletion reversed the positive effects of BLACAT1 deletion on CRC cells. Moreover, our data showed that miR-519d-3p directly targeted CREB1 and BLACAT1 sponged miR-519d-3p to regulate CREB1 expression. Besides, CREB1 disrupted the bio-functional results above from BLACAT1 suppression. Additionally, BLACAT1 knockdown promoted CRC cells sensitivity to OXA in vivo. Conclusion: BLACAT1 mediated the progression of CRC and OXA-resistance by miR-519d-3p/CREB1 axis. Keywords: colorectal cancer, BLACAT1, oxaliplatin, miR-519d-3p, CREB1